GENSTAR THERAPEUTICS CORP
10QSB, EX-27, 2000-11-03
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: GENSTAR THERAPEUTICS CORP, 10QSB, 2000-11-03
Next: FISHMAN JAY A LTD/MI, 13F-HR, 2000-11-03



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF GENSTAR THERAPEUTICS CORP. AS OF AND FOR THE NINE MONTHS
ENDED SEPTEMBER 30, 2000.
</LEGEND>

<S>                             <C>                     <C>
<PERIOD-TYPE>                   9-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-1999
<PERIOD-START>                             JAN-01-2000             JAN-01-1999
<PERIOD-END>                               SEP-30-2000             SEP-30-1999
<CASH>                                       9,019,425                 921,994
<SECURITIES>                                15,140,534                       0
<RECEIVABLES>                                   13,421                       0
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                            24,243,772               1,045,663
<PP&E>                                       2,185,741                 726,489
<DEPRECIATION>                                 386,917                 157,368
<TOTAL-ASSETS>                              26,278,189               1,826,913
<CURRENT-LIABILITIES>                        1,234,407                 597,952
<BONDS>                                              0                       0
                                0                       0
                                         88                      88
<COMMON>                                        22,598                  12,104
<OTHER-SE>                                (19,181,150)            (12,524,390)
<TOTAL-LIABILITY-AND-EQUITY>                26,278,189               1,826,913
<SALES>                                              0                       0
<TOTAL-REVENUES>                               113,396                  67,201
<CGS>                                                0                       0
<TOTAL-COSTS>                                7,544,309               2,453,669
<OTHER-EXPENSES>                               845,229                  16,197
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                            (71,076)               (348,898)
<INCOME-PRETAX>                            (6,656,760)             (2,719,161)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                        (6,656,760)             (2,719,161)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                               (6,656,760)             (2,719,161)
<EPS-BASIC>                                      (.33)                   (.27)
<EPS-DILUTED>                                    (.33)                   (.27)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission